legislation: 100-s-997
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100-s-997 | 100 | s | 997 | Alzheimer's Disease Research Act of 1987 | Health | 1987-04-09 | 1987-04-24 | Committee on Labor and Human Resources requested executive comment from Health and Human Services Department, OMB. | Senate | Sen. Pell, Claiborne [D-RI] | RI | D | P000193 | 11 | Alzheimer's Disease Research Act of 1987 - Requires the Director of the National Institute on Aging to provide for the conduct of clinical trials on the efficacy of the use of tetrahydroaminoacridine to retard the progression of Alzheimer's disease and to improve the functioning of individuals with such disease. Authorizes appropriations for FY 1988 through 1990. | 2025-08-28T20:05:43Z | https://www.congress.gov/bill/100th-congress/senate-bill/997 |